208 related articles for article (PubMed ID: 2752698)
1. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
[TBL] [Abstract][Full Text] [Related]
2. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
Blume CD; Williams RL
Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
Casner PR; Dillon KR
J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence evaluation of a triamterene-hydrochlorothiazide generic product: a new bioequivalence index for fixed-dose combinations.
Hamidi M; Shahbazi MA; Azimi K
Regul Toxicol Pharmacol; 2011 Feb; 59(1):149-56. PubMed ID: 21193005
[TBL] [Abstract][Full Text] [Related]
6. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
Woo J; Woo KS; Kin T; Vallance-Owen J
Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
Williams RL; Clark T; Blume CD
Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
[TBL] [Abstract][Full Text] [Related]
8. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
9. [Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)].
Herrmann JM; Hiemstra S; Hoenig B
Dtsch Med Wochenschr; 1981 Sep; 106(36):1138-43. PubMed ID: 7261940
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two combined diuretics in the treatment of essential hypertension.
Verhiest W; Baehre M; Volkers P
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
[TBL] [Abstract][Full Text] [Related]
12. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
Düsing R; Kramer HJ
Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
[TBL] [Abstract][Full Text] [Related]
13. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
14. Effects of muzolimine and of a combination of hydrochlorothiazide/triamterene in healthy subjects and in nephrotic patients.
Riechers G; Futerova M; Hanisch M; Ritter W; Kühn K
Z Kardiol; 1985; 74 Suppl 2():103-8. PubMed ID: 4002782
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
Möhrke W; Knauf H; Mutschler E
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):447-52. PubMed ID: 9352394
[TBL] [Abstract][Full Text] [Related]
16. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
[TBL] [Abstract][Full Text] [Related]
17. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
[No Abstract] [Full Text] [Related]
18. Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide.
Blume CD; Williams RL; Upton RA; Lin ET; Benet LZ
Am J Med; 1984 Nov; 77(5A):59-61. PubMed ID: 6496560
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hypertension with a fixed calcium antagonist-diuretic combination. Observations from treatment of 5,595 patients].
Klaus D
Fortschr Med; 1995 Mar; 113(7):90-6. PubMed ID: 7750891
[TBL] [Abstract][Full Text] [Related]
20. In vitro/in vivo evaluation of hydrochlorothiazide in experimental hydrochlorothiazide/triamterene combination tablets in beagle dogs.
Ritschel WA; Turkoglu M; Lipps D; Warner A; Sakr A
Arzneimittelforschung; 1991 Mar; 41(3):208-11. PubMed ID: 1867656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
